FDA Will Drop Two-Study Requirement for New Drug Approvals, Aiming to Speed Access
FDA Will Drop Two-Study Requirement for New Drug Approvals, Aiming to Speed Access is drawing significant interest across the industry.
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval of new drugs, the latest change from Trump administration officials vowing to speed up the availability of certain medical products.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- ‘Blatant killing of sovereign leader’: China condemns US-Israel attack on Iran, warns against wider conflict
- Azerbaijani soldiers are assisting those fleeing the conflict in Iran at the Astara border
- Police to probe Youth Congress activist's money laundering plaint against MA Shahanas, who called out Mamkootathil
- Blue Owl's Lipschultz dismisses concerns over AI disrupting software businesses
Source: Original →